Central Atlantic Stroke Network (SCANR)
Stroke Central Atlantic Network for Research (SCANR)
This network connects hospitals across the Mid-Atlantic to speed access to new stroke treatments and support people who have had a stroke, including Black and pediatric patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11238423 on NIH RePORTER |
What this research studies
SCANR is a group of hospitals and universities in the DC–Baltimore–Charlottesville area that work together to find better ways to prevent, treat, and recover from stroke. Sites screen and enroll people with acute stroke, at-risk adults, and children into a range of trials and registries covering emergency treatments, prevention, rehabilitation, and imaging studies. Because the network includes major hospitals and specialty centers, it can offer trials quickly after stroke and reach communities with high stroke rates, including many Black/African American patients. If you're treated at a participating hospital, clinicians may ask if you'd like to join a study or donate samples to help future patients.
Who could benefit from this research
Good fit: People recently hospitalized for stroke, those at high risk for stroke, or children receiving care at participating Mid-Atlantic hospitals are the best matches for involvement.
Not a fit: People who live outside the Mid-Atlantic region or whose medical condition doesn't meet specific trial criteria may not benefit directly from this network.
Why it matters
Potential benefit: Could provide faster access to new treatments and more research focused on communities with high stroke rates.
How similar studies have performed: Regional and national stroke networks have successfully completed trials that changed care, and SCANR builds on that established model.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Turkeltaub, Peter Ethan — Georgetown University
- Study coordinator: Turkeltaub, Peter Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.